Developing a novel, fungicidal therapeutic to treat coccidioidomycosis
Ended Project Grant Awarded Last action
- Award ID
- R44AI125017
- Recipient
-
Amplyx Pharmaceuticals, Inc. UEI N4A8X52DCND5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,460,969
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Place of performance
- San Diego, CA 92121, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $732,374 | |
| Original award | $728,595 |
Quick answers
Who received award R44AI125017?
R44AI125017 was awarded to Amplyx Pharmaceuticals, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 1, 2016.
How much is award R44AI125017 worth?
$1,460,969 has been obligated on R44AI125017.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award